DRG Instruments GmbH of Marburg at MEDICA 2018 in Düsseldorf -- MEDICA - World Forum for Medicine

DRG Instruments GmbH

Frauenbergstr. 18, 35039 Marburg
Telephone +49 6421 17000
Fax +49 6421 170050

Hall map

MEDICA 2018 hall map (Hall 3): stand A69

Fairground map

MEDICA 2018 fairground map: Hall 3

Our range of products

Product categories

  • 02  Laboratory Technology
  • 02.01  Analyser systems / equipment

Analyser systems / equipment

  • 03  Diagnostic Tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.01  Immuno assay testing

Immuno assay testing

  • 03  Diagnostic Tests
  • 03.02  Immunochemistry testing, immunology testing
  • 03.02.04  Other equipment for immunochemistry and immunology

Other equipment for immunochemistry and immunology

  • 03  Diagnostic Tests
  • 03.05  Infectious immunology testing
  • 03.05.02  Microbiological diagnosis, virology, equipment and systems for

Microbiological diagnosis, virology, equipment and systems for

About us

Company details

DRG Instruments GmbH, founded in 1973 as a subsidiary of DRG Intl. Inc., USA, is a diagnostics manufacturer and distributor with successful operations in over 110 countries.

The DRG Group focuses on high technology medical diagnostic areas such as Diabetes Diagnosis, Gynecology, Oncology, Immunology, Infectious Diseases and Toxicology.

The highly skilled DRG staff of medical, clinical, marketing and service specialists is experts at taking innovative technology to market through local territory knowledge and contacts, end-user training, education and cost effective financial and logistical support. The DRG-Development and Immunoassay production facilities are located in Marburg, Germany, in addition to OEM manufacturing in the USA.

A wide range of new, occasionally unique, ELISA kits have been developed. The DRG ELISA kits compete effectively in both price and performance in all major world diagnostics markets. To complete the diagnostic reagent line, DRG supplies the clinical laboratory with all necessary equipment, including a semi-automated microtiterplate processor, the DRG E-LizaMat 3000, and fully automated Open Systems for microtiterplates, which are fully compatible with all Elisas.

DRG offers the FIRST fully automated Analyzer for Immunoassays, Clinical Chemistry and Immunoturbidimetry: DRG:HYBRiD-XL®.

The DRG Group operates through a network of DRG Subsidiary Companies in Germany, Poland, Russia, and the Czech Republic, and through Distributors in Europe, the Middle East, Asia, Africa and the Pacific Region. This infrastructure offers access to specialized medical markets in most major countries around the world.

More Less